Pembrolizumab on pre-existing inclusion body myositis: a case report

BACKGROUND: Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased risk of exacerbation. We describe the first c...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Rheumatol
Main Authors: Uchio, Naohiro, Unuma, Atsushi, Kakumoto, Toshiyuki, Osaki, Masao, Zenke, Yoshitaka, Sakuta, Kenichi, Kubota, Akatsuki, Uesaka, Yoshikazu, Toda, Tatsushi, Shimizu, Jun
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493364/
https://ncbi.nlm.nih.gov/pubmed/32944686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-020-00144-5
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares